VHOSPITAL.CLINIC · Serology Test

Serology (ELISA): Diagnosing Leishmaniasis

Serology (ELISA) is a clinically validated diagnostic investigation for Leishmaniasis. Enzyme-linked immunosorbent assay detecting IgG/IgM antibodies against parasite-specific antigens — used for diagnosis, monitoring, and surveillance.

SerologyCondition-first view →

About Serology (ELISA)

Enzyme-linked immunosorbent assay detecting IgG/IgM antibodies against parasite-specific antigens — used for diagnosis, monitoring, and surveillance.

What Serology (ELISA) Reveals About Leishmaniasis

In the diagnostic work-up for Leishmaniasis, Serology (ELISA) contributes to confirming or excluding the diagnosis, monitoring treatment response, or detecting complications. Leishmaniasis is caused by Leishmania protozoa transmitted by sandfly bites, presenting in visceral, cutaneous, or mucocutaneous forms.

Test Procedure

Serology (ELISA) is performed according to standard laboratory or clinical protocols. Sample type, timing, and processing requirements vary — consult your physician or laboratory for current local procedures.

Result Interpretation

A positive result in the appropriate clinical context supports the diagnosis of Leishmaniasis. A negative result does not always exclude the diagnosis — interpretation depends on pre-test probability, disease stage, and immune status. Consult an infectious disease specialist for complex cases.

Sensitivity & Specificity

Sensitivity and specificity vary by laboratory, antigen preparation, and patient population. Published performance characteristics should be interpreted in the context of local disease prevalence and patient risk factors.

Clinical Indications

  • Clinical suspicion of Leishmaniasis based on symptoms, exposure history, or travel
  • Eosinophilia with compatible clinical presentation
  • Unexplained systemic symptoms in a patient from or travelling to an endemic area
  • Pre-treatment confirmation before antiparasitic therapy
  • Post-treatment follow-up assessment

Results Requiring Urgent Action

  • ⚠️Test result inconsistent with clinical presentation — seek specialist advice
  • ⚠️Severe or rapidly worsening symptoms alongside positive test result
  • ⚠️Immunocompromised patient with any positive parasitological result
  • ⚠️Pregnant patient with confirmed or suspected Leishmaniasis

FAQ: Serology (ELISA) for Leishmaniasis

How is Leishmaniasis diagnosed using Serology (ELISA)?

Serology (ELISA) is used as part of the diagnostic workup for Leishmaniasis. Enzyme-linked immunosorbent assay detecting IgG/IgM antibodies against parasite-specific antigens — used for diagnosis, monitoring, and surveillance. A positive result in the appropriate clinical context supports the diagnosis, but should always be interpreted alongside symptoms, travel history, and other investigations.

How accurate is Serology (ELISA) for diagnosing Leishmaniasis?

Performance characteristics of Serology (ELISA) for Leishmaniasis depend on the stage of infection and patient immune status. Consult current WHO guidelines or an infectious disease specialist for the most current sensitivity and specificity data for your setting.

When should I see a doctor after a Serology (ELISA) result for Leishmaniasis?

Any positive parasitological result should be discussed with a physician promptly. Seek urgent medical care if you have fever, severe abdominal pain, difficulty breathing, jaundice, or any neurological symptoms alongside the test result.

Other Leishmaniasis Diagnostic Tests

🦠

Leishmaniasis — Full Clinical Guide

Leishmaniasis is caused by Leishmania protozoa transmitted by sandfly bites, presenting in visceral, cutaneous, or mucocutaneous forms. Visceral leishmaniasis (kala-azar) causes fever, splenomegaly, and pancytopaenia. Amphotericin B and miltefosine are first-line treatments.

Do your symptoms suggest Leishmaniasis?

Get a structured AI clinical assessment — possible parasitic causes, recommended diagnostic tests, and next steps.

Start Free AI Analysis →

Explore More

Medical References

Content on this page is informed by evidence-based clinical sources including: